These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25861163)

  • 1. Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis.
    Xue H; Yang Y; Zhang Y; Song S; Zhang L; Ma L; Yang T; Liu H
    Mediators Inflamm; 2015; 2015():621072. PubMed ID: 25861163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Th17 cytokine levels are altered in Hashimoto's thyroiditis.
    Konca Degertekin C; Aktas Yilmaz B; Balos Toruner F; Kalkanci A; Turhan Iyidir O; Fidan I; Yesilyurt E; Cakır N; Kustimur S; Arslan M
    Cytokine; 2016 Apr; 80():13-7. PubMed ID: 26928603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible role of CD4⁺CD25(high)Foxp3⁺/CD4⁺IL-17A⁺ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis.
    Xue H; Yu X; Ma L; Song S; Li Y; Zhang L; Yang T; Liu H
    Endocrine; 2015 Dec; 50(3):665-73. PubMed ID: 25771887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto's thyroiditis.
    Liu Y; Tang X; Tian J; Zhu C; Peng H; Rui K; Wang Y; Mao C; Ma J; Lu L; Xu H; Wang S
    Int J Mol Sci; 2014 Nov; 15(12):21674-86. PubMed ID: 25429429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis.
    Figueroa-Vega N; Alfonso-Pérez M; Benedicto I; Sánchez-Madrid F; González-Amaro R; Marazuela M
    J Clin Endocrinol Metab; 2010 Feb; 95(2):953-62. PubMed ID: 20016049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of CD4+CD161+CD196+ and CD4+IL-17+ Th17 cells in the peripheral blood of young patients with Hashimoto's thyroiditis and Graves' disease].
    Bossowski A; Moniuszko M; Idźkowska E; Dąbrowska M; Jeznach M; Sawicka B; Borysewicz-Sańczyk H; Bossowska A; Rusak M; Bodzenta-Łukaszyk A
    Pediatr Endocrinol Diabetes Metab; 2012; 18(3):89-95. PubMed ID: 23146786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; a case control study.
    Ayaz T; Sahin SB; Sahin OZ; Cure MC; Sumer F; Ilkkilic K
    Thyroid Res; 2014; 7(1):11. PubMed ID: 25506398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIF promotes Th17 cell differentiation in Hashimoto's thyroiditis by binding HVEM and activating NF-κB signaling pathway.
    Liu Z; Li Z; Yan G; Lin C; Luo Y; Ye Y; Zeng X; Yao J
    Int Immunopharmacol; 2023 Aug; 121():110494. PubMed ID: 37331297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A higher frequency of circulating IL-22(+)CD4(+) T cells in Chinese patients with newly diagnosed Hashimoto's thyroiditis.
    Guo H; Peng D; Yang XG; Wang Y; Xu BC; Ni JS; Meng W; Jiang YF
    PLoS One; 2014; 9(1):e84545. PubMed ID: 24404171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
    Kristensen B
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients.
    Li D; Cai W; Gu R; Zhang Y; Zhang H; Tang K; Xu P; Katirai F; Shi W; Wang L; Huang T; Huang B
    Clin Immunol; 2013 Dec; 149(3):411-20. PubMed ID: 24211715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis.
    Shi Y; Wang H; Su Z; Chen J; Xue Y; Wang S; Xue Y; He Z; Yang H; Zhou C; Kong F; Liu Y; Yang P; Lu L; Shao Q; Huang X; Xu H
    Scand J Immunol; 2010 Sep; 72(3):250-5. PubMed ID: 20696023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased proportions of Tc17 cells and NK cells may be risk factors for disease progression in Hashimoto's thyroiditis.
    Liu Y; You R; Yu N; Gong Y; Qu C; Zhang Y; Lu G; Huang Y; Zhang H; Gao Y; Gao Y; Guo X
    Int Immunopharmacol; 2016 Nov; 40():332-338. PubMed ID: 27668571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease.
    Qin Q; Liu P; Liu L; Wang R; Yan N; Yang J; Wang X; Pandey M; Zhang JA
    Braz J Med Biol Res; 2012 Dec; 45(12):1202-8. PubMed ID: 23090124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
    Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
    Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
    Nanba T; Watanabe M; Inoue N; Iwatani Y
    Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders.
    Vitales-Noyola M; Ramos-Levi AM; Martínez-Hernández R; Serrano-Somavilla A; Sampedro-Nuñez M; González-Amaro R; Marazuela M
    Endocrine; 2017 Sep; 57(3):409-417. PubMed ID: 28669056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating Tfh17 and PD-1
    Zhao J; Chen Y; Zhao Q; Shi J; Yang W; Zhu Z; Yu W; Guan J; Song Y; Wu H; Jin W; Zhou Y; Liu J
    Autoimmunity; 2018 Nov; 51(7):352-359. PubMed ID: 30345813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of circulating sTWEAK in the pathogenesis of Hashimoto's thyroiditis - a pilot study.
    Altay M; Ateş İ; Yılmaz FM; Topçuoğlu C; Kaplan M
    Endokrynol Pol; 2016; 67(6):562-566. PubMed ID: 26884302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile.
    Baños-Hernández CJ; Navarro-Zarza JE; Bucala R; Hernández-Bello J; Parra-Rojas I; Ramírez-Dueñas MG; García-Arellano S; Hernández-Palma LA; Machado-Sulbarán AC; Muñoz-Valle JF
    Clin Rheumatol; 2019 Jun; 38(6):1643-1654. PubMed ID: 30747392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.